Hinge Health Crushes Q2, Raises Guidance, Acquires Cylinder Health, and Ups Buyback to $496.5M
HNGE has more than doubled off its 52-week low of $30.08.
Summary
Q2 revenue hit $212.8M (53% YoY growth), full-year guidance was raised, a $105M acquisition of Cylinder Health adds GI care, and the buyback program expanded to $496.5M.
Key Events · Earnings and Guidance · HNGE
-
Q2 Revenue Beats by $11.8M
Revenue of $212.8M grew 53% YoY, exceeding the $201M consensus estimate. Non-GAAP operating income of $61.5M (29% margin) more than doubled from $26.1M a year ago.
-
Full-Year Guidance Raised
Revenue guidance raised to $856M-$860M (46% YoY growth at midpoint), and non-GAAP operating income guidance raised to $236M-$244M (101% YoY growth), reflecting strong momentum.
-
Acquires Cylinder Health for $105M
Enters gastrointestinal care, a $135B market, by acquiring Cylinder Health for $105M in cash. The deal adds nearly 100 clients and 2M covered lives, with an integrated GI program expected in 2027.
-
Buyback Authorization Increased by $300M
Board increased the share repurchase program by $300M to a total of $496.5M, with $300M available for future repurchases. The company has already bought back $196.5M of stock.
Analysis · HNGE · Technology
A standout quarter saw revenue reach $212.8M, up 53% year-over-year and well above the $201M consensus. Full-year revenue guidance was raised to $858M at the midpoint, implying 46% growth, while the non-GAAP operating income outlook jumped by over 100%. In a strategic expansion, the company is acquiring Cylinder Health for $105M in cash, entering the large and underserved gastrointestinal care market. Signaling confidence in the stock, the board also increased the share repurchase authorization by $300M, bringing the total to $496.5M. Together, these announcements mark a major positive inflection point.
How filings like this one have moved
In the 30 days to Sep 18, 2026, 40.2% of the 371 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HNGE was trading at $77.01 on NYSE in the Technology sector, with a market capitalization of approximately $6.1B. The 52-week trading range was $30.08 to $91.50. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.